{
    "nctId": "NCT02839473",
    "briefTitle": "Hydrosorb\u00ae Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial",
    "officialTitle": "Hydrosorb\u00ae Versus Control (Water Based Spray) in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Radiation Dermatitis",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 278,
    "primaryOutcomeMeasure": "local treatment failure defined as interruption of radiotherapy because of skin radiotoxicity or change of local care because skin alteration.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women treated by normo fractionated radiotherapy for breast cancer\n* Presenting grade 1 or 2 radiation dermatitis during the treatment and who provided their written informed consent were included in the study.\n\nExclusion criteria:\n\n* Were male patients\n* Radiation dermatitis already treated or caused by another treatment\n* Subjects deprived of their freedom or under guardianship\n* Subjects in whom medical follow-up was impossible\n* A cancer wound or skin flap on the irradiated zone\n* A history of allergic skin reaction\n* Concomitant chemotherapy or concomitant bevacizumab therapy and bilateral irradiation.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}